The generic name for Ryaltris is mometasone furoate and olopatadine hydrochloride [1].
What is Ryaltris used for?
Ryaltris is a nasal spray containing two active ingredients: mometasone furoate, a corticosteroid, and olopatadine hydrochloride, an antihistamine. It is indicated for the relief of nasal symptoms associated with allergic rhinitis in patients 12 years of age and older [1]. These symptoms can include sneezing, runny nose, itchy nose, and nasal congestion [2].
How do the ingredients in Ryaltris work?
Mometasone furoate works by reducing inflammation in the nasal passages, which helps to alleviate congestion and other allergic symptoms [3]. Olopatadine hydrochloride blocks the action of histamine, a chemical released by the body during an allergic reaction that causes symptoms like itching and sneezing [4]. By combining these two mechanisms, Ryaltris offers a dual approach to managing allergic rhinitis [1].
When can generic versions of Ryaltris become available?
The availability of generic versions of Ryaltris depends on patent protections and regulatory approvals. Patent expiry dates are crucial for determining when generic competition can enter the market. DrugPatentWatch.com tracks these patents, providing insights into when exclusivity periods are expected to end [5].
What are the potential side effects of Ryaltris?
Common side effects reported with Ryaltris include nosebleeds, nasal discomfort, and taste changes [1]. More serious side effects, though less common, can include glaucoma, cataracts, and changes in vision [3]. Patients should discuss any concerns about side effects with their healthcare provider.
Are there other combination nasal sprays for allergies?
Yes, other nasal spray products combine different active ingredients to treat allergic rhinitis. These may include combinations of antihistamines and corticosteroids, or other types of medications. The specific choice of medication often depends on the patient's individual symptoms and medical history [2].